A next-generation obesity drug from Eli Lilly reached a new level of weight loss in a late clinical trial, matching levels generally seen in those who've had bariatric surgery, company officials said Thursday.
Why it matters: The results challenge assumptions of how much the drugs can achieve and could help Lilly reinforce its position at the front of an increasingly competitive market.
The U.S. response to the Ebola outbreak is drawing new warnings from public health experts about the impact of the Trump administration's global health policies, including the dismantlement of USAID and itswithdrawal from the World Health Organization.
Why it matters: While officials are rushing to get resources to stricken parts of Africa, infectious disease experts fear the administration's other actions are weakening critical networks needed for a rapid response in a densely populated, politically unstable part of the world.
Why it matters: The move could open the task force up to more political influence. It comes as the administration prepares to vet new applicants to the committee, a process in which the chairs would typically be involved.
GHO Capital of London has agreed to merge with Singapore-based rival CBC Group, forming a dedicated health care investment firm with over $21 billion in assets under management.
Why it matters: This is about scaling for survival, as generalist PE giants have begun to crowd out smaller players in health care.
An Ebola outbreak in parts of Central and East Africa is fueling concern about another global health crisis.
Why it matters: WHO this week declared Ebola a public health emergency of international concern, but experts say the chances of a global pandemic remain slim.
Finding a new commissioner is only the beginning of what the Trump administration needs to do to rebuild the Food and Drug Administration — and none of it is easy.
Why it matters: More than a year of upheaval has left the agency's leadership decimated and its reputation for predictable, evidence-based decisions damaged.
The ongoing Ebola surge has public health experts anxious about the world's capacity to contain its spread.
The big picture: Ebola epidemics aren't new, but the current outbreak has been identified as the rare Bundibugyo strain, which has no vaccine, and is located in a populated, mobile and conflict-stricken part of the world.
Do you dread making small talk or getting drawn into a dull conversation about the weather?
Buck up! Conversations about topics people think are boring typically wind up being enjoyable, according to an intriguing study recently published in the Journal of Personality and Social Psychology.
Why it matters: Social interaction is good for you — plenty of research finds it enhances well-being and makes people feel happy.
